Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company” or 'Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or 'Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial ...

Ardelyx (ARDX) is emerging as a compelling, yet risky, small-cap biotech opportunity. The company has made significant ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

Saldanha said he hasn’t yet fully figured out how to deploy much of the proceeds of the licensing deal, but added that he ...

U.S. stocks traded mostly flat on Monday as investors reacted to President Donald Trump's announcement of a 30% tariff on all ...

About This EventArtiva Biotherapeutics (Nasdaq: ARTV), visits the Nasdaq MarketSite in Times Square. Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe, and ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

The consolidation of the Philippine Dealing System Holdings Corp. boosted the earnings of the Philippine Stock Exchange Inc. ...